🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

EBD RCT Trial in Living Donor Liver Transplantation

RecruitingNAAges 19 Years - 79 YearsAllSeoul National University Hospital
NCT04622540 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study was designed to demonstrate incidence of biliary complication rates after living donor liver transplantation according to the implantation of external biliary drainage throug duct-to-duct anastomosis site.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Living donor liver transplantation * Adult patient (\>=18 years old) * Patients who are available for at least 3 year follow-up after LDLT Exclusion Criteria: * Patients requring hepaticojejunostomy due to anatomical factor or underlying disease * Re-transplantation * Multiorgan transplantation * Emergency transplantation
💊

What it tests

  • External biliary drainage
📍

Where

1 site
Seoul National University Hospital
Seoul, South Korea
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy